# Hisamitsu Pharmaceutical

> Hisamitsu Pharmaceutical is a VC fund in Tosu backing Medical, Compliance and Market Research. See 2 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Tosu, Japan
- Total investments: 2
- Last investment: Jul 2025
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/hisamitsu-pharmaceutical-co.-inc.
- Website: http://www.hisamitsu.co.jp/english

Hisamitsu Pharmaceutical is a VC fund in Tosu focused on Medical and Compliance. Hisamitsu Pharmaceutical was founded in the mid-19th century under the name of Komatsuya. The company went on to create a large variety of health-related products, and has been the organization responsible for the promotion of new ideas based on its comprehensive system encompassing research, development, manufacturing, and sales. Salonpas wasin fact introduced in 1934, and with its outright effectiveness achieved the position of market leadership it continues to hold today. Salonpas was developed through the application of Asahi Mankinko, the prototype therapeutic patch or that we introduced back in 1903.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 1 | 50% |
| Compliance | 1 | 50% |
| Market Research | 1 | 50% |
| Emergency Medicine | 1 | 50% |
| Management Consulting | 1 | 50% |

6 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 1 | 50% |
| Series B | 1 | 50% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| ReEir | ReEir is a research firm that develops global regenerative medicine and cell therapy products for ulcer patients. | $3.9M | Seed | Jul 17, 2025 |  |
| GAIA BioMedicine | GAIA BioMedicine is Based on the intellectual property and technology. | $11.9M | Series B | Sep 21, 2021 |  |

2 of 2 investments shown.

## Co-investors
- [01Booster](https://shizune.co/investors/profile/01booster-df8c) — VC Fund, 1 deal together
- [Asahi Group Holdings](https://shizune.co/investors/profile/asahi-group-holdings) — VC Fund, 1 deal together
- [CEJ Capital](https://shizune.co/investors/profile/cej-capital) — VC Fund, 1 deal together
- [Izul](https://shizune.co/investors/profile/izul) — VC Fund, 1 deal together
- [Osaka University Venture Capital](https://shizune.co/investors/profile/osaka-university-venture-capital) — VC Fund, 1 deal together
- [Sakura Juji](https://shizune.co/investors/profile/sakura-juji) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Hisamitsu Pharmaceutical invest in?

Hisamitsu Pharmaceutical invests primarily in Medical, Compliance and Market Research startups, most often at Seed and Series B stage. Most of the 2 investments tracked by Shizune back companies in Japan. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Hisamitsu Pharmaceutical last invest?

The most recent investment recorded for Hisamitsu Pharmaceutical closed in Jul 2025. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co